Similar Search Results

The determinants of pharmaceutical research and development expenditures

Grabowski, Henry G.; Vernon, John M. - In: Journal of evolutionary economics : JEE 10 (2000) 1/2, pp. 201-215

Persistent link: https://www.econbiz.de/10001435911

Innovation and structural change in pharmaceuticals and biotechnology

Grabowski, Henry G. - In: Industrial and corporate change 3 (1994) 2, pp. 435-449

Persistent link: https://www.econbiz.de/10001173541

Returns to R&D on new drug introductions in the 1980s

Grabowski, Henry G. - In: Journal of health economics 13 (1994) 4, pp. 383-406

Persistent link: https://www.econbiz.de/10001174777

Pioneers, imitators, and generics : a simulation model of Schumpeterian competition

Grabowski, Henry G. - In: The quarterly journal of economics 102 (1987) 3, pp. 491-525

Persistent link: https://www.econbiz.de/10001048921

R&D costs, innovative output and firm size in the pharmaceutical industry

DiMasi, Joseph A. - In: International journal of the economics of business 2 (1995) 2, pp. 201-219

Persistent link: https://www.econbiz.de/10001333584

A new look at the returns and risks to pharmaceutical R&D

Grabowski, Henry G. - In: Management science : journal of the Institute for … 36 (1990) 7, pp. 804-821

Persistent link: https://www.econbiz.de/10001093354

Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act

Grabowski, Henry G. - In: The journal of law & economics 35 (1992) 2, pp. 331-350

Persistent link: https://www.econbiz.de/10001139354

The regulation of pharmaceuticals : balancing the benefits and risks

Grabowski, Henry G.; Vernon, John M. - 1983

Persistent link: https://www.econbiz.de/10004778249

Effective patent life in pharmaceuticals

Grabowski, Henry G.; Vernon, John M. - In: International journal of technology management : IJTM 19 (2000) 1-2, pp. 98-120

Persistent link: https://www.econbiz.de/10006984499

Longer Patents for Increased Generic Competition : The Waxman-Hatch Act after One Decade

Grabowski, Henry G.; Vernon, John M. - 2013

The 1984 Drug Price Competition and Patent Term Restoration Act (the Waxman-Hatch Act) is unique in many ways. This Law was the first change in U.S. patent terms since 1861. It simultaneously lowered the barrier to entry for generic drug firms and increased patent terms for new drugs delayed by...

Persistent link: https://www.econbiz.de/10014084787